Bailard, Inc. Iovance Biotherapeutics, Inc. Put Options Transaction History
Bailard, Inc.
- $3.6 Billion
- Q2 2024
Put Options
1 transactions
Others Institutions Holding IOVA
# of Institutions
320Shares Held
238MCall Options Held
1.27MPut Options Held
1.68M-
Vanguard Group Inc Valley Forge, PA26MShares$253 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY25.9MShares$253 Million6.02% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$234 Million28.39% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$207 Million0.0% of portfolio
-
State Street Corp Boston, MA12.6MShares$123 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.54B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...